Brain signals linked to sweet taste preference discovered

Updated on: March 17,2025

Brain signals linked to sweet taste preference discovered

Updated on:March 17,2025

Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,

Updated on: January 14,2025

Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,

Updated on:January 14,2025

Scientists discover a variation of the genome predisposing to Alzheimer's disease

by IDIBELL-Bellvitge Biomedical Research InstituteExample of cells of a patient with advanced Alzheimer's with an altered PM20D1 gene. Credit: IDIBELLAn article published inNature Medic

Updated on: March 09,2024

Scientists discover a variation of the genome predisposing to Alzheimer's disease

by IDIBELL-Bellvitge Biomedical Research InstituteExample of cells of a patient with advanced Alzheimer's with an altered PM20D1 gene. Credit: IDIBELLAn article published inNature Medic

Updated on:March 09,2024

New tools reveal neuropeptides, not neurotransmitters, encode danger in the brain

bySalk InstituteTwo images of nerve endings in the amygdala (where fear signals are received and interpreted). On the left, there are no labels and two distinct vesicles in the nerve endings can

Updated on: July 30,2024

New tools reveal neuropeptides, not neurotransmitters, encode danger in the brain

bySalk InstituteTwo images of nerve endings in the amygdala (where fear signals are received and interpreted). On the left, there are no labels and two distinct vesicles in the nerve endings can

Updated on:July 30,2024

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa

Updated on: April 08,2024

A common risk factor for Alzheimer's disease may predispose carriers to severe COVID-19

by University of HelsinkiCredit: Pixabay/CC0 Public DomainA study conducted at the University of Helsinki and the Helsinki University Hospital (HUS) suggests that the APOE4 allele may also increa

Updated on:April 08,2024

Old drug offers new hope to treat Alzheimer's disease

by Gladstone InstitutesVarious pills. Credit: WikipediaScientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau

Updated on: February 26,2024

Old drug offers new hope to treat Alzheimer's disease

by Gladstone InstitutesVarious pills. Credit: WikipediaScientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau

Updated on:February 26,2024

Women with ovarian removal have unique risk and resilience factors for Alzheimer disease, research finds

byUniversity of TorontoCredit: Pixabay/CC0 Public DomainResearch published by a team of researchers from the University of Toronto in collaboration with colleagues from the University of Alberta

Updated on: December 11,2024

Women with ovarian removal have unique risk and resilience factors for Alzheimer disease, research finds

byUniversity of TorontoCredit: Pixabay/CC0 Public DomainResearch published by a team of researchers from the University of Toronto in collaboration with colleagues from the University of Alberta

Updated on:December 11,2024

Visualization tool helps scientists spot neuronal activity patterns in mountains of data

byHoward Hughes Medical InstituteBenchmarking Rastermap on simulated data with multiplexed neural activity. Credit:Nature Neuroscience(2024). DOI: 10.1038/s41593-024-01783-4Neuroscie

Updated on: November 07,2024

Visualization tool helps scientists spot neuronal activity patterns in mountains of data

byHoward Hughes Medical InstituteBenchmarking Rastermap on simulated data with multiplexed neural activity. Credit:Nature Neuroscience(2024). DOI: 10.1038/s41593-024-01783-4Neuroscie

Updated on:November 07,2024

Alzheimer's disease destroys neurons that keep us awake

by University of California, San FranciscoCredit: CC0 Public DomainResearchers and caregivers have noted that excessive daytime napping can develop long before the memory problems associated with

Updated on: April 10,2024

Alzheimer's disease destroys neurons that keep us awake

by University of California, San FranciscoCredit: CC0 Public DomainResearchers and caregivers have noted that excessive daytime napping can develop long before the memory problems associated with

Updated on:April 10,2024

Researchers use AI-powered method to identify genetic epilepsies earlier than current genetic diagnosis

byChildren's Hospital of PhiladelphiaCredit: CC0 Public DomainDiagnosing the genetic cause of a disease can aid in finding therapies and directing treatment, but often these diagnoses occur

Updated on: August 08,2024

Researchers use AI-powered method to identify genetic epilepsies earlier than current genetic diagnosis

byChildren's Hospital of PhiladelphiaCredit: CC0 Public DomainDiagnosing the genetic cause of a disease can aid in finding therapies and directing treatment, but often these diagnoses occur

Updated on:August 08,2024

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on: April 10,2024

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on:April 10,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024